000 05847cam a2200433Ii 4500
001 96626
003 ES-MaUEC
005 20230102112803.0
006 m o d
007 cr cnu|||unuuu
008 171025s2017 sz a o 001 0 eng d
020 _a3319632450
_q(electronic bk.)
020 _a9783319632452
_q(electronic bk.)
020 _z3319632442
020 _z9783319632445
_q(print)
040 _aN$T
_beng
_erda
_epn
_cN$T
_dGW5XE
_dN$T
_dEBLCP
_dYDX
_dUAB
_dAZU
_dOCLCF
_dUPM
_dIOG
_dCOO
_dOCLCQ
_dCASUM
_dOCLCO
_dES-MaUEC
_bspa
050 4 _aRB170
_b2017 EB
245 0 0 _aPulmonary vasculature redox signaling in health and disease
_cYong-Xiao Wang, editor.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea (xxi, 422 páginas)
_bilustraciones (algunas a color)
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
490 0 _aAdvances in experimental medicine and biology
_x0065-2598
_vvolume 967
500 _aIncludes index.
500 _a
_bSpringer Biomedical and Life Sciences eBooks 2017 English+International
505 0 _a""Preface""; ""About the Editor""; ""Contents""; ""Contributors""; ""Adventitial Fibroblast Nox4 Expression and ROS Signaling in Pulmonary Arterial Hypertension""; ""1 Pulmonary Arterial Hypertension""; ""2 Reactive Oxygen Species, NADPH Oxidase and PAH""; ""3 Nox4 Expression in PAH""; ""4 Enzymatic Properties of Nox4""; ""5 Role of the Adventitial Fibroblast and Nox4 in PAH""; ""References""; ""Role of Transcription Factors in Pulmonary Artery Smooth Muscle Cells: An Important Link to Hypoxic Pulmonary Hypertension""; ""1 Introduction""
505 8 _a""2 Roles of Transcription Factors in Lung Diseases""""2.1 NF-κB""; ""2.2 AP-1""; ""2.3 STAT""; ""2.4 TCF7""; ""2.5 NRF2""; ""2.6 HIF-1""; ""3 Redox-Sensitive Signaling in SMC Regulation: Role of TFs""; ""4 Conclusion and Future Perspective""; ""References""; ""Molecular Basis of Nitrative Stress in the Pathogenesis of Pulmonary Hypertension""; ""1 Introduction""; ""2 Molecular Mechanisms of Nitrative Stress in the Pathogenesis of Pulmonary Hypertension""; ""3 Molecular Sources of Reactive Nitrogen Species in Pulmonary Hypertension""
505 8 _a""3.2 Glucose-6-Phosphate Dehydrogenase Inhibition Relaxes Pulmonary Arteries, Reduces Inflammatory Cytokines and Cell Proliferation, and Induces Cell Apoptosis""""3.3 Glucose-6-Phosphate Dehydrogenase Inhibitor Treatment Reduces Pulmonary Hypertension""; ""4 G6PD and CD133 (+) Cells in Pulmonary Hypertension""; ""4.1 CD133 (+) Cells""; ""4.2 Glucose Metabolism and G6PD in CD133 (+) Cells""; ""4.3 CD133 (+) Cells Increase in Pulmonary Hypertension""; ""4.4 CD133 (+) Cells Exacerbate Pulmonary Arterial Hypertension""; ""References""
505 8 _a""4 Molecular Sources of Reactive Oxygen Species in Pulmonary Hypertension""""5 Nitrative Stress in Pulmonary Hypertension Patients""; ""6 Conclusions""; ""References""; ""Pentose Shunt, Glucose-6-­Phosphate Dehydrogenase, NADPH Redox, and Stem Cells in Pulmonary Hypertension""; ""1 Pulmonary Hypertension""; ""2 Warburg Effect and Pulmonary Hypertension""; ""3 Glucose Metabolism, Pentose Shunt, and Glucose-­6-­Phosphate Dehydrogenase in Pulmonary Hypertension""; ""3.1 Glucose Metabolism is Altered in Pulmonary Hypertension""
505 8 _a""Redox Regulation of the Superoxide Dismutases SOD3 and SOD2 in the Pulmonary Circulation""""1 Introduction""; ""2 The Extracellular SOD3 Enzyme""; ""2.1 Characterization of SOD3""; ""2.2 Redox Regulation of SOD3""; ""2.2.1 Intrasubunit Disulfide Bonds""; ""2.2.2 Intersubunit Disulfide Bond""; ""2.2.3 Proteolytic Cleavage of SOD3""; ""2.3 Regulation of SOD3 Activity""; ""2.4 Regulation of SOD3 Gene Expression""; ""2.5 Redox Regulation by SOD3 in Pulmonary Hypertension""; ""3 The Mitochondrial SOD2 Enzyme""; ""3.1 Characterization of SOD2""
520 3 _aThe main goal of this book is to form a high-quality platform in which well-known and emerging pioneering basic, translational and clinical scientists can present their latest, exciting findings in the studies of redox signaling in the pulmonary vasculature. Content from outstanding investigators with unique expertise and skills of molecular and cell biology, biochemistry, physiology, pharmacology, biophysics, biotechnology and medicine will update our current out-of-date concepts with new knowledge. Rapidly increasing scientific studies have gathered a large volume of novel and important information on redox signaling in healthy and diseased pulmonary vasculature. This volume covers the need for a cohesive book to display state-of-the-art advances in the field. The second major aim of this book is to help direct future research. Redox signaling is a major molecular process involved in almost every physiologic cellular response in the pulmonary vasculature including energy metabolism, host defense, gene expression, contraction, proliferation, and migration. Aberrancy in this important signaling pathway leads to a critical role in the development of nearly all pulmonary diseases, such as pulmonary hypertension, cor pulmonale, pulmonary edema, and vasculitis, among others.
650 7 _aOxígeno
_xPhysiological effect.
_2embne
_0(OCoLC)fst00796285
_0
_9146654
700 1 _aWang, Yong-Xiao,
_eeditor literario
_985156
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-63245-2
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aEBOOK, asignarmaterias, EBSPRINGER_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c96626
_d96626
_x1